The company’s goal is to translate science into highly innovative medicines, thereby honoring the company motto to bring Better Health and a Brighter Future to patients. More than 50,000 dedicated employees in approximately 80 countries and regions around the world are committed to improving the quality of life for patients and to cooperating with all our partners in health care.
Takeda focuses its efforts on developing highly innovative medicines that have a lasting effect on people’s lives by opening up new opportunities through targeted treatment options. Takeda has a strong research pipeline.
Specifically, Takeda showcases a comprehensive product portfolio covering a wide spectrum of rare and complex diseases, as reflected in the company’s global therapeutic areas: Oncology, Gastro-Enterology, Neurosciences, Rare Diseases, Plasma-Derived Products and Vaccines.
Over 1.300 professionals work for Takeda Belgium, making it one of the 10 largest pharmaceutical companies in Belgium. Takeda’s position is Belgium is strengthened by its global production site in Lessines.
The Lessines site has been in operation for almost 50 years and specializes in immunoglobulin purification with filling and packaging capabilities for plasma-derived therapies. It is also a packaging center for products used to treat blood disorders.
The site’s workforce strives to reflect the diversity of the patients it serves. With over 15 different nationalities, the sites’ employees are working tirelessly serving patients with rare diseases and other specialized conditions 24 hours a day, 7 days a week.
Takeda acts for the Planet, in fact:
We installed 8000 solar panels that will produce 3GWh per year, equivalent to the annual consumption of 700 families.
The new wastewater recycling facility will reduce city water consumption by 90% by 2023, equivalent to 600 million liters of water per year.
The new waste storage facility will reduce container transport by 2,500 km per year, equivalent to 13 tons of CO2 per year.